These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8689939)

  • 1. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
    Chauret N; Nicoll-Griffith D; Friesen R; Li C; Trimble L; Dubé D; Fortin R; Girard Y; Yergey J
    Drug Metab Dispos; 1995 Dec; 23(12):1325-34. PubMed ID: 8689939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation.
    Zhang KE; Naue JA; Arison B; Vyas KP
    Chem Res Toxicol; 1996 Mar; 9(2):547-54. PubMed ID: 8839061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
    Chauret N; Li C; Ducharme Y; Trimble LA; Yergey JA; Ramachandran C; Nicoll-Griffith DA
    Drug Metab Dispos; 1995 Jan; 23(1):65-71. PubMed ID: 7720527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methylisoeugenol in liver microsomes of human, rat, and bovine origin.
    Cartus AT; Merz KH; Schrenk D
    Drug Metab Dispos; 2011 Sep; 39(9):1727-33. PubMed ID: 21632962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).
    Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E
    Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of N-(5-chloro-2-methylphenyl)-N'-(2-methylpropyl)thiourea: species comparison and identification of a novel thiocarbamide-glutathione adduct.
    Stevens GJ; Hitchcock K; Wang YK; Coppola GM; Versace RW; Chin JA; Shapiro M; Suwanrumpha S; Mangold BL
    Chem Res Toxicol; 1997 Jul; 10(7):733-41. PubMed ID: 9250406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
    Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
    Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo.
    Valadon P; Dansette PM; Girault JP; Amar C; Mansuy D
    Chem Res Toxicol; 1996 Dec; 9(8):1403-13. PubMed ID: 8951246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A.
    Ring BJ; Parli CJ; George MC; Wrighton SA
    Drug Metab Dispos; 1994; 22(3):352-7. PubMed ID: 8070310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
    Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
    J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
    Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
    Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
    Balani SK; Goldman ME; Kauffman LR; Varga SL; O'Brien JA; Smith SJ; Olah TV; Ramjit HG; Schorn TW; Pitzenberger SM
    Drug Metab Dispos; 1993; 21(4):598-604. PubMed ID: 7690697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in beta-oxidative metabolism of a thromboxane A2-receptor antagonist [(+)-S-145] in rat, dog and monkey.
    Yamaguchi Y; Touchi A; Baba T; Matsubara T
    Xenobiotica; 2001 Mar; 31(3):125-33. PubMed ID: 11465390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.